These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19116634)

  • 21. Systemic protein therapy for recessive dystrophic epidermolysis bullosa: how far are we from clinical translation?
    Hovnanian A
    J Invest Dermatol; 2013 Jul; 133(7):1719-21. PubMed ID: 23760051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.
    Wong T; Gammon L; Liu L; Mellerio JE; Dopping-Hepenstal PJ; Pacy J; Elia G; Jeffery R; Leigh IM; Navsaria H; McGrath JA
    J Invest Dermatol; 2008 Sep; 128(9):2179-89. PubMed ID: 18385758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunofluorescence studies using skin sections of recessive dystrophic epidermolysis bullosa patients indicated that the antigen of anti-p200 pemphigoid is not a fragment of type VII collagen.
    Liu Y; Shimizu H; Hashimoto T
    J Dermatol Sci; 2003 Aug; 32(2):125-9. PubMed ID: 12850304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
    Dang N; Murrell DF
    Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scanning electron microscopy of a blister roof in dystrophic epidermolysis bullosa.
    Almeida HL; Monteiro L; Marques e Silva R; Rocha NM; Scheffer H
    An Bras Dermatol; 2013; 88(6):966-8. PubMed ID: 24474107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa.
    Kühl T; Mezger M; Hausser I; Handgretinger R; Bruckner-Tuderman L; Nyström A
    Mol Ther; 2015 Aug; 23(8):1368-1379. PubMed ID: 25858020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An RNA-targeted therapy for dystrophic epidermolysis bullosa.
    Peking P; Koller U; Duarte B; Murillas R; Wolf S; Maetzig T; Rothe M; Kocher T; García M; Brachtl G; Schambach A; Larcher F; Reichelt J; Bauer JW; Murauer EM
    Nucleic Acids Res; 2017 Sep; 45(17):10259-10269. PubMed ID: 28973459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
    Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
    J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
    Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
    Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression.
    McGrath JA; Ishida-Yamamoto A; O'Grady A; Leigh IM; Eady RA
    J Invest Dermatol; 1993 Apr; 100(4):366-72. PubMed ID: 8454899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
    Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
    Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
    Hainzl S; Peking P; Kocher T; Murauer EM; Larcher F; Del Rio M; Duarte B; Steiner M; Klausegger A; Bauer JW; Reichelt J; Koller U
    Mol Ther; 2017 Nov; 25(11):2573-2584. PubMed ID: 28800953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients.
    Goto M; Sawamura D; Nishie W; Sakai K; McMillan JR; Akiyama M; Shimizu H
    J Invest Dermatol; 2006 Dec; 126(12):2614-20. PubMed ID: 16778792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.
    Fritsch A; Loeckermann S; Kern JS; Braun A; Bösl MR; Bley TA; Schumann H; von Elverfeldt D; Paul D; Erlacher M; Berens von Rautenfeld D; Hausser I; Fässler R; Bruckner-Tuderman L
    J Clin Invest; 2008 May; 118(5):1669-79. PubMed ID: 18382769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa.
    Tartaglia G; Fuentes I; Patel N; Varughese A; Israel LE; Park PH; Alexander MH; Poojan S; Cao Q; Solomon B; Padron ZM; Dyer JA; Mellerio JE; McGrath JA; Palisson F; Salas-Alanis J; Han L; South AP
    EMBO Mol Med; 2024 Apr; 16(4):870-884. PubMed ID: 38462666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recurrent 'hot spot' glycine substitution mutation, G2043R in COL7A1, induces dominant dystrophic epidermolysis bullosa associated with intracytoplasmic accumulation of pro-collagen VII.
    Nishie W; Natsuga K; Nakamura H; Ito T; Toyonaga E; Sato H; Shimizu H
    J Dermatol Sci; 2014 Jul; 75(1):69-71. PubMed ID: 24794830
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy.
    Gorell ES; Nguyen N; Siprashvili Z; Marinkovich MP; Lane AT
    Br J Dermatol; 2015 Sep; 173(3):821-3. PubMed ID: 25703736
    [No Abstract]   [Full Text] [Related]  

  • 39. Systemic therapy for a genetic skin disease.
    Bruckner-Tuderman L
    N Engl J Med; 2010 Aug; 363(7):680-2. PubMed ID: 20818860
    [No Abstract]   [Full Text] [Related]  

  • 40. Dystrophic epidermolysis bullosa: from disease biology to biologic therapy.
    Samuelov L
    Br J Dermatol; 2024 Jul; 191(2):159-160. PubMed ID: 38680069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.